Volume | 7,517 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 2.6101 | Mínimo Máximo |
|||||
Minimo del Dia | 2.36 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Lixte Biotechnology Holdings Inc | LIXT | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
2.45 | 2.36 | 2.6101 | 2.4604 | 2.38 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
78 | 7,517 | US$ 2.44 | US$ 18,373 | - | 1.58 - 9.50 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
16:04:55 | 25 | US$ 2.20 | USD |
Información Financiera Lixte Biotechnology Holdings Inc LIXT
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
5.53M | 2.25M | - | 0 | -5.09M | -2.26 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Lixte Biotechnology Holdings Inc LIXT
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
08/5/2024 | 08:25 | GlobeNewswire Inc. | LIXTE Biotechnology Co-Sponsoring International Scientific.. |
24/4/2024 | 14:25 | AllPennyStocks.com | Mixed Shelf Filing Gives Micro Cap Delayed Boost |
27/3/2024 | 14:35 | AllPennyStocks.com | Biotech Steals The Show Following Pre-Clinical Data.. |
27/3/2024 | 07:30 | GlobeNewswire Inc. | NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD.. |
21/3/2024 | 07:30 | GlobeNewswire Inc. | LIXTE Provides Update on Progress with LB-100 as a PP2A.. |
27/2/2024 | 15:59 | Edgar (US Regulatory) | Form 8-K - Current report |
27/2/2024 | 07:30 | GlobeNewswire Inc. | Professor René Bernards to Present New Pre-Clinical Data on.. |
26/2/2024 | 09:48 | Edgar (US Regulatory) | Form 8-K - Current report |
26/2/2024 | 07:30 | GlobeNewswire Inc. | LIXTE Biotechnology Enters into Exclusive Immune Oncology.. |
29/1/2024 | 07:30 | GlobeNewswire Inc. | First Patient Dosed with LIXTE’s LB-100 and GSK’s.. |
28/11/2023 | 16:21 | Edgar (US Regulatory) | Form 8-K - Current report |
13/11/2023 | 13:28 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos LIXT
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.75 | 2.89 | 2.25 | 2.39 | 20,796 | -0.2896 | -10.53% |
1 Month | 3.45 | 3.59 | 2.25 | 2.84 | 15,318 | -0.9896 | -28.68% |
3 Months | 2.36 | 4.40 | 1.90 | 3.44 | 600,300 | 0.1004 | 4.25% |
6 Months | 2.96 | 4.42 | 1.69 | 3.41 | 298,161 | -0.4996 | -16.88% |
1 Year | 6.50 | 9.50 | 1.58 | 3.90 | 195,874 | -4.04 | -62.15% |
3 Years | 25.80 | 49.50 | 1.58 | 17.66 | 730,207 | -23.34 | -90.46% |
5 Years | 38.50 | 71.90 | 1.58 | 21.70 | 720,060 | -36.04 | -93.61% |